Gameiro A, Nascimento C, Correia J, Ferreira F. HER2-Targeted Immunotherapy and Combined Protocols Showed Promising Antiproliferative Effects in Feline Mammary Carcinoma Cell-Based Models. Cancers (Basel). 2021;13: pubmed 出版商

Duffy C, Sorolla A, Wang E, Golden E, Woodward E, Davern K, et al. Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer. NPJ Precis Oncol. 2020;4:24 pubmed 出版商

Hegde M, Joseph S, Pashankar F, Derenzo C, Sanber K, Navai S, et al. Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma. Nat Commun. 2020;11:3549 pubmed 出版商

Bartkowiak K, Koch C, Gärtner S, Andreas A, Gorges T, Pantel K. In Vitro Modeling of Reoxygenation Effects on mRNA and Protein Levels in Hypoxic Tumor Cells upon Entry into the Bloodstream. Cells. 2020;9: pubmed 出版商

Noyan S, Gurdal H, Gur Dedeoglu B. Involvement of miR-770-5p in trastuzumab response in HER2 positive breast cancer cells. PLoS ONE. 2019;14:e0215894 pubmed 出版商

Kennedy S, Han J, Portman N, Nobis M, Hastings J, Murphy K, et al. Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer. Breast Cancer Res. 2019;21:43 pubmed 出版商

Mieszkowska M, Piasecka D, Potemski P, Dębska Szmich S, Rychlowski M, Kordek R, et al. Tetraspanin CD151 impairs heterodimerization of ErbB2/ErbB3 in breast cancer cells. Transl Res. 2019;207:44-55 pubmed 出版商

Baiocchi G, Molfino S, Baronchelli C, Giacopuzzi S, Marrelli D, Morgagni P, et al. Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series. World J Gastroenterol. 2017;23:8000-8007 pubmed 出版商

Bai L, Guo C, Zhao Y, Gao J, Li M, Shen C, et al. SUVmax of 18F-FDG PET/CT correlates to expression of major chemotherapy-related tumor markers and serum tumor markers in gastric adenocarcinoma patients. Oncol Rep. 2017;37:3433-3440 pubmed 出版商

Liu W, Barnette A, Andreansky S, Landgraf R. ERBB2 Overexpression Establishes ERBB3-Dependent Hypersensitivity of Breast Cancer Cells to Withaferin A. Mol Cancer Ther. 2016;15:2750-2757 pubmed

Zhao H, Yu Z, Zhao L, He M, Ren J, Wu H, et al. HDAC2 overexpression is a poor prognostic factor of breast cancer patients with increased multidrug resistance-associated protein expression who received anthracyclines therapy. Jpn J Clin Oncol. 2016;46:893-902 pubmed

Liu W, Landgraf R. Phosphorylated and unphosphorylated serine 13 of CDC37 stabilize distinct interactions between its client and HSP90 binding domains. Biochemistry. 2015;54:1493-504 pubmed 出版商

Hamill K, Hiroyasu S, Colburn Z, Ventrella R, Hopkinson S, Skalli O, et al. Alpha actinin-1 regulates cell-matrix adhesion organization in keratinocytes: consequences for skin cell motility. J Invest Dermatol. 2015;135:1043-1052 pubmed 出版商

Elias A, Crayton S, Warden Rothman R, Tsourkas A. Quantitative comparison of tumor delivery for multiple targeted nanoparticles simultaneously by multiplex ICP-MS. Sci Rep. 2014;4:5840 pubmed 出版商

Dakhova O, Rowley D, Ittmann M. Genes upregulated in prostate cancer reactive stroma promote prostate cancer progression in vivo. Clin Cancer Res. 2014;20:100-9 pubmed 出版商

Chatterjee S, Malhotra R, Varghese F, Bukhari A, Patil A, Budrukkar A, et al. Quantitative immunohistochemical analysis reveals association between sodium iodide symporter and estrogen receptor expression in breast cancer. PLoS ONE. 2013;8:e54055 pubmed 出版商

Ceran C, Cokol M, Cingoz S, Tasan I, Ozturk M, Yagci T. Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-?. BMC Cancer. 2012;12:450 pubmed 出版商

Epis M, Barker A, Giles K, Beveridge D, Leedman P. The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cells. J Biol Chem. 2011;286:41442-54 pubmed 出版商

Massey A, Williamson D, Browne H, Murray J, Dokurno P, Shaw T, et al. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells. Cancer Chemother Pharmacol. 2010;66:535-45 pubmed 出版商

Epis M, Giles K, Barker A, Kendrick T, Leedman P. miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer. J Biol Chem. 2009;284:24696-704 pubmed 出版商

Jensen M, Schoepfer J, Radimerski T, Massey A, Guy C, Brueggen J, et al. NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models. Breast Cancer Res. 2008;10:R33 pubmed 出版商

Cai W, Rambaud J, Teboul M, Masse I, Benoit G, Gustafsson J, et al. Expression levels of estrogen receptor beta are modulated by components of the molecular clock. Mol Cell Biol. 2008;28:784-93 pubmed

Parsy C, Chapman C, Barnes A, Robertson J, Murray A. Two-step method to isolate target recombinant protein from co-purified bacterial contaminant SlyD after immobilised metal affinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;853:314-9 pubmed